sym-trinitrobenzene has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falk, P; Fridkis-Hareli, M; Mond, JJ; Morecki, S; Nabet, C; Pecht, I; Slavin, S | 1 |
| Bergman, B; Haskins, K; Norbury-Glaser, M; Wegmann, D | 1 |
2 other study(ies) available for sym-trinitrobenzene and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
Topics: Animals; Antibody Formation; Antigen Presentation; Antigens, T-Independent; Autoantibodies; Autoantigens; Autoimmune Diseases; Dextrans; Diabetes Mellitus, Type 1; Drug Administration Schedule; Encephalomyelitis, Autoimmune, Experimental; Female; Ficoll; Freund's Adjuvant; Haptens; Hemocyanins; Hydroxyquinolines; Immunization; Immunologic Factors; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred NOD; Myelin Basic Protein; Peptide Fragments; Serum Albumin, Bovine; Solubility; Trinitrobenzenes | 1997 |
High efficiency presentation of TNP-conjugated islet antigen to islet-specific T cells by a hybrid B cell line expressing TNP-specific surface Ig.
Topics: Adenoma, Islet Cell; Animals; Antigen-Presenting Cells; Antigens, Neoplasm; Autoantigens; B-Lymphocytes; Cell Line; Diabetes Mellitus, Type 1; Haptens; Hybrid Cells; Interleukin-2; Islets of Langerhans; Lymphocyte Activation; Mice; Mice, Inbred NOD; Ovalbumin; Receptors, Antigen, B-Cell; T-Lymphocytes; Trinitrobenzenes | 1992 |